Showing 161 - 180 results of 434 for search '"polio vaccine"', query time: 0.21s Refine Results
  1. 161

    The Last Mile—Community Engagement and Conditional Incentives to Accelerate Polio Eradication in Pakistan: Study Protocol for a Quasi-Experimental Trial by Jai K. Das, Amira Khan, Farhana Tabassum, Zahra Ali Padhani, Atif Habib, Mushtaq Mirani, Abdu R. Rahman, Zahid Ali Khan, Arjumand Rizvi, Imran Ahmed, Zulfiqar Bhutta

    Published 2023-09-01
    “…Community mobilization plays a vital role in raising awareness and can help reduce polio vaccine refusals. The objective of this study will be to decrease polio vaccine refusals and zero-dose vaccines by motivating behavior change through the provision of conditional–collective–community-based incentives (C3Is) based on a reduction in polio vaccine refusals. …”
    Get full text
    Article
  2. 162

    Epidemic poliomyelitis, post-poliomyelitis sequelae and the eradication program by Margaret M Peel

    Published 2020-01-01
    “…The Salk inactivated polio vaccine (IPV) became available in Australia in 1956 and the Sabin live attenuated oral polio vaccine (OPV) was introduced in 1966. …”
    Get full text
    Article
  3. 163

    Polio Supplementary Immunization Activities During COVID-19 Pandemic: Experience from Penampang District, Sabah, Malaysia by Sam Froze Jiee, Melvin Ebin Bondi, Muhammad Ezmeer Emiral, Anisah Jantim

    Published 2021-07-01
    “…Methods: A series of meticulous planning, healthcare staff training, advocacy, and community engagement activities were conducted by the Penampang District Health Office. Bivalent Oral Polio Vaccine (bOPV) and monovalent Oral Polio Vaccine were administered over the period of 1 year via these methods: house to house, drive-through, static, and mobile posts. …”
    Get full text
    Article
  4. 164

    Sailing in Uncharted Waters: Carefully Navigating the Polio Endgame. by Elizabeth Miller, T Jacob John

    Published 2016-10-01
    “…Jacob John discuss the path towards global polio eradication and the challenges, strategies, and necessary precautions around oral polio vaccine cessation.…”
    Get full text
    Article
  5. 165

    WHO and UNICEF estimates of national infant immunization coverage: methods and processes by Anthony Burton, Roeland Monasch, Barbara Lautenbach, Marta Gacic-Dobo, Maryanne Neill, Rouslan Karimov, Lara Wolfson, Gareth Jones, Maureen Birmingham

    Published 2009-07-01
    “…WHO and the United Nations Children's Fund (UNICEF) annually review data on immunization coverage to estimate national coverage with routine service delivery of the following vaccines: bacille Calmette-Guérin; diphtheria-tetanus-pertussis, first and third doses; either oral polio vaccine or inactivated polio vaccine, third dose of either; hepatitis B, third dose; Haemophilus influenzae type b, third dose; and a measles virus-containing vaccine, either for measles alone or in the form of a combination vaccine, one dose. …”
    Get full text
    Article
  6. 166

    The Pathology of Poliomyelitis and the Vaccines and Nonvaccine Therapy by Chen Yushuo, Yue Tianrui, Zhang Zixiao

    Published 2021-01-01
    “…Vaccines are the main means of preventing and controlling polio, and many different vaccines have been invented in the process of fighting polio. Inactivated polio vaccine (IPV) and oral polio vaccine (OPV) are the two main vaccines. …”
    Get full text
    Article
  7. 167

    T-Cells Proliferation and Serum Cytokine levels in Type 1 Diabetic Children by Eman Mahdi Saleh

    Published 2011-12-01
    “…Methods: In 60 Iraqi T1DM children with recent onset of T1DM, Lymphocyte proliferation was analyzed using Methylthiazol tetrazolium (MTT) assay by culturing Peripheral Blood Lymphocytes (PBLs) with Coxsackie Virus B5 (CVB5), Adenovirus, and Polio vaccine. Serum Interferon-γ, IL-10 and IL-6 were quantified by sandwich ELISA. …”
    Get full text
    Article
  8. 168

    The burden of vaccine hesitancy for routine immunization in Yaounde-Cameroon: A cross-sectional study by Martin Ndinakie Yakum, Atanga D. Funwie, Atem Bethel Ajong, Marcellin Tsafack, Linda Evans Eba Ze, Zahir Shah

    Published 2022-01-01
    “…In total, vaccine hesitancy was reported in 137(25.90[22.35–29.80] %), and oral polio vaccine(OPV) was the most affected vaccine with hesitancy of 10%. …”
    Get full text
    Article
  9. 169

    Evaluation of Household Perception about Polio Immunization, Prior and After the Direct Supervision of District Administration in Karachi by Syed Saif-ur-Rehman, M. Abu Zar Wajidi

    Published 2019-03-01
    “…Moreover, according to respon-   dents the knowledge and awareness in polio vaccination has increased by 13% (55% to 68%), while the belief on polio vaccine has increased to 11% (63% to 74%). …”
    Get full text
    Article
  10. 170

    Circulating vaccine-derived polioviruses: current state of knowledge by Kew Olen M., Wright Peter F., Agol Vadim I., Delpeyroux Francis, Shimizu Hiroyuki, Nathanson Neal, Pallansch Mark A.

    Published 2004-01-01
    “…Particular attention must be given to areas where the risks for wild poliovirus circulation have been highest, and where the highest rates of polio vaccine coverage must be maintained to suppress cVDPV emergence.…”
    Get full text
    Article
  11. 171

    The burden of vaccine hesitancy for routine immunization in Yaounde-Cameroon: A cross-sectional study. by Martin Ndinakie Yakum, Atanga D Funwie, Atem Bethel Ajong, Marcellin Tsafack, Linda Evans Eba Ze, Zahir Shah

    Published 2022-01-01
    “…In total, vaccine hesitancy was reported in 137(25.90[22.35-29.80] %), and oral polio vaccine(OPV) was the most affected vaccine with hesitancy of 10%. …”
    Get full text
    Article
  12. 172

    Monkeypox: Another Sexually Transmitted Infection? by Alfonso J. Rodriguez-Morales, Gustavo Lopardo

    Published 2022-06-01
    “…Monkeypox virus is a zoonotic DNA virus (Poxviridae family), identified in 1958 in Asian monkeys (mostly <i>Macaca fascicularis</i>) in a polio vaccine research animal facility in Copenhagen, Denmark [...]…”
    Get full text
    Article
  13. 173

    Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011 by Nicksy Gumede, Vongani Muthambi, Barry D. Schoub

    Published 2012-06-01
    “…Patients with primary immunodeficiency are prone to persistently excrete Sabin-like virus after administration of live-attenuated oral polio vaccine and have an increased risk for vaccine-derived paralytic polio. …”
    Get full text
    Article
  14. 174

    Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines by Yoshikazu Honda-Okubo, Jeremy Baldwin, Nikolai Petrovsky

    Published 2021-04-01
    “…This study provides valuable insights into the complexity of the formulation of multivalent polio vaccines and supports the further development of adjuvanted antigen-sparing TIPV vaccines in the fight to eradicate polio.…”
    Get full text
    Article
  15. 175

    Small Session Size and Big Vial Size: Operational Research Assessing Open Vial Vaccine Wastage at the Service Delivery Points in the Mandalay Region of Myanmar During 2018 by Aung Naing Oo, Pruthu Thekkur, Aye Mya Cha Thar, Kyaw Ko Ko Htet, Htar Htar Lin

    Published 2020-04-01
    “…The vaccine wastage rates for Bacillus Calmette–Guérin (BCG) (54.9%), inactivated polio vaccine (28.3%), and measles-rubella (27.4%) were higher than the WHO indicative rates. …”
    Get full text
    Article
  16. 176

    Poliomyelitis amidst the COVID-19 pandemic in Africa: Efforts, challenges and recommendations by Olivier Uwishema, Emmanuel Ebuka Elebesunu, Oumnia Bouaddi, Arushi Kapoor, Samaa Akhtar, Fortune Benjamin Effiong, Adhiraj Chaudhary, Helen Onyeaka

    Published 2022-07-01
    “…However, the emergence of Vaccine-derived Poliovirus due to genetic reversions in the live attenuated oral polio vaccine has posed a significant impediment to global polio eradication efforts. …”
    Get full text
    Article
  17. 177

    Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial by Muhammad Atif Habib, MPH, Sajid Soofi, FCPS, Prof Simon Cousens, DipMathStat, Saeed Anwar, MPH, Najib ul Haque, FRCP, Prof Imran Ahmed, MSc, Noshad Ali, MPH, Rehman Tahir, MBA, Prof Zulfiqar A Bhutta, PhD

    Published 2017-06-01
    “…Innovative interventions are urgently needed to strengthen community buy-in, to increase the coverage of oral polio vaccine (OPV) and other routine immunisations, and to enhance immunity through the introduction of inactivated polio vaccine (IPV) in combination with OPV. …”
    Get full text
    Article
  18. 178

    Establishment of realtime RT-PCR assay to detect polio virus in the Acute Flaccid Paralysis laboratory surveillance by Nike Susanti, Sinta Purnamawati, Krisna NA Pangesti, Vivi Setiawaty

    Published 2016-07-01
    “…<p><em><strong>Abstrak</strong></em></p><p><em><strong>Latar belakang:</strong> Virus polio indigenous terakhir ditemukan di Indonesia tahun 1995 tetapi ancaman viruspolio impor dan mutasi virus dari Oral Polio Vaccine (OPV) menjadi Vaccine Derived Poliovirus (VDPV)masih berlanjut. …”
    Get full text
    Article
  19. 179

    Establishment of realtime RT-PCR assay to detect polio virus in the Acute Flaccid Paralysis laboratory surveillance by Nike Susanti, Vivi Setiawaty

    Published 2016-07-01
    “…<p><em><strong>Abstrak</strong></em></p><p><em><strong>Latar belakang:</strong> Virus polio indigenous terakhir ditemukan di Indonesia tahun 1995 tetapi ancaman viruspolio impor dan mutasi virus dari Oral Polio Vaccine (OPV) menjadi Vaccine Derived Poliovirus (VDPV)masih berlanjut. …”
    Get full text
    Article
  20. 180